TONYA GOODMAN: Open Payments
NPI 1134738461 · PROSPECT, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$774 in 36 payments from 7 companies in 2025. Trend: 2023 $188 · 2024 $669 · 2025 $774
Food & beverage: $774
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $257 |
| Axsome Therapeutics, Inc. | 5 | $200 |
| Vanda Pharmaceuticals Inc. | 3 | $82 |
| Otsuka America Pharmaceutical, Inc. | 3 | $77 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $66 |
| Alkermes, Inc. | 3 | $59 |
| Janssen Pharmaceuticals, Inc | 2 | $32 |
Products named: VRAYLAR, Auvelity, FANAPT, REXULTI, CAPLYTA, ARISTADA, SPRAVATO.
Industry payments across CT — which companies pay providers there.
